Intel Logo

We thank our main sponsor Intel

BIH Award for Women Scientists in Computational Biology

Berlin Institute of Health Logo

The Berlin Institute of Health was founded in 2013, when Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association joined forces with the aim of pushing forward translational medicine based on a systems medicine approach through the accelerated transfer of research findings into hospitals, and in turn feeding clinical findings back into basic biomedical research. BIH has been a Körperschaft des öffentlichen Rechts since April 2015, with the Charité and MDC as independent organs within it. Thanks to new scientific and technological developments in biomedicine, BIH is set to create new diagnostic, therapeutic and preventive approaches in medicine for the benefit of human health.

As excellence in translational research is furthered through gender equality, supporting the equal participation of women and men is an important objective in all undertakings.

The BIH Award for Women Scientists in Computational Biology is established with the goal to encourage and support women scientists in the emerging field of translational bioinformatics and computational biology. The Award will be granted as a sign of recognition of major contributions by women scientists within this field of research. Award winners will be inspiring role models for future generations of women in computational biology.

The BIH Women Award in Computational Biology will be given for an excellent dissertation in the field of computational biology and is endowed with 10.000 Euro.

The BIH Award for Women Scientists in Computational Biology Ceremony will be held on 13. September 2016 at the German Conference for Bioinformatics in Berlin.

For the call click here or visit the BIH website.

R&D Session - Developments in commercial research

As a novelty at the GCB, and in Germany, this year’s conference will feature a session presenting the research and development done by industry laboratories in Pharma and Hardware development. The session will feature research talks, impulse presentations and an open session to get in contact with industry researchers to foster collaborations or future employments.


Max Planck Institute for Molecular Genetics and the IMPRS-CBSC

Research at the Max Planck Institute for Molecular Genetics (MPIMG) concentrates on genome analysis of man and other organisms to contribute to a global understanding of many of the biological processes in the organism, and to elucidate the mechanism behind many human diseases. The Graduate School of the Institute, the International Max Planck Research School for Computational Biology and Scientific Computing (IMPRS-CBSC) is a joint program of the MPIMG and FUB.

Partnership proposal

Seminaris Berlin

We are currently looking for collaborators to present their industry research in bioinformatics, screening, drug development, or method development in an impulse talk or poster presentation. The planned industry session is meant as a social gathering for researchers interested in industry cooperations and young scientists with ambitions for an industrial career. The format is open for suggestions and may include closed personal meetings based on mutual interests. Connected with a participation we appreciate a four-digit sponsoring.

Please contact us if you are interested in participating in the conference or if you have any questions:


GCB 2016
Chair: Prof. Knut Reinert, FUB-MI/MPIMG
Coordinator: Dr. Fabian Feutlinske, IMPRS-CBSC/MPIMG
phone: 030/8413-1154